YonaLink, TrialJectory get $1m grant for patient recruitment toolTwo digital health companies – YonaLink and TrialJectory – have received a grant to develop a tool designed Share XYonaLink, TrialJectory get $1m grant for patient recruitment toolhttps://pharmaphorum.com/news/yonalink-trialjectory-get-1m-grant-for-patient-recruitment-tool/
Capricor preps phase 3 for Duchenne cell therapy as it seeks a partnerCapricor Therapeutics’ bid to find a partner for its Duchenne muscular dystrophy (DMD) cell therapy CAP-1002 could get Share XCapricor preps phase 3 for Duchenne cell therapy as it seeks a partnerhttps://pharmaphorum.com/news/capricor-preps-phase-3-for-duchenne-cell-therapy-as-it-seeks-a-partner/
Rumour mill says Acceleron is speeding towards $11bn saleUS biopharma company Acceleron is the next company heading for a takeover by a big pharma group – Share XRumour mill says Acceleron is speeding towards $11bn salehttps://pharmaphorum.com/news/rumour-mill-says-acceleron-is-speeding-towards-11bn-sale/
The benefits of being a family-run pharma companyThe third generation of his family to hold a leadership role at Chiesi Group, Giacomo Chiesi reflects on Share XThe benefits of being a family-run pharma companyhttps://pharmaphorum.com/sales-marketing/chiesi-family-run-pharma-company-benefits/
Addressing the HIV epidemic in Eastern Europe and Central AsiaWorking in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences. 2021 Share XAddressing the HIV epidemic in Eastern Europe and Central Asiahttps://pharmaphorum.com/patients/gilead-hiv-epidemic-eastern-europe-central-asia/
It’s time to do better for patients with rare neurological disordersGlobal Gene’s Craig Martin introduces a new patient identification initiative that strives to improve diagnosis and access to Share XIt’s time to do better for patients with rare neurological disordershttps://pharmaphorum.com/patients/global-genes-rare-neurological-disorder-research/
Cancer research faces uncertain post-COVID landscapeThere’s a bright future ahead for cancer research in the UK, but only if the government is able Share XCancer research faces uncertain post-COVID landscapehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/cancer-research-faces-uncertain-post-covid-landscape/
Surprise pandemic lessons for pharmaAsk people in most western nations to think back to 2019 and consider what they would have said Share XSurprise pandemic lessons for pharmahttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/surprise-pandemic-lessons-for-pharma/
Lessons from the first generation of cell and gene oncology trialsAdvances in cell and gene science are paving the way for transformative cancer treatments, but there are still Share XLessons from the first generation of cell and gene oncology trialshttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/lessons-from-the-first-generation-of-cell-gene-oncology-trials/
Using AI to make a big impact for emerging and mid-sized biopharma companies Share XUsing AI to make a big impact for emerging and mid-sized biopharma companieshttps://pharmaphorum.com/webinars/using-ai-to-make-a-big-impact-for-emerging-and-mid-sized-biopharma-companies/
The digital transformation of pharma’s physician engagement strategies Share XThe digital transformation of pharma’s physician engagement strategieshttps://pharmaphorum.com/webinars/digital-transformation-pharma-engagement-p360/
Customer engagement and pharma’s field force future Share XCustomer engagement and pharma’s field force futurehttps://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/
4 ways emerging pharma companies can harness marketing contentRapid creation of compliant marketing content is increasingly important and there are ways emerging pharma companies can stay Share X4 ways emerging pharma companies can harness marketing contenthttps://pharmaphorum.com/whitepapers/emerging-pharma-marketing-content-veeva/
How pharma can help the post-COVID recovery of European cancer careThe new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and Share XHow pharma can help the post-COVID recovery of European cancer carehttps://pharmaphorum.com/whitepapers/pharma-covid-recovery-cancer-care/
4 ways to embed data-driven best practice in pharma HCP communicationsVirtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for Share X4 ways to embed data-driven best practice in pharma HCP communicationshttps://pharmaphorum.com/whitepapers/4-ways-to-embed-data-driven-best-practice-in-pharma-hcp-communications/
Virtual engagement and collaborations: the pharmaphorum podcast Share XVirtual engagement and collaborations: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/virtual-engagement-impetus-digital
Biotech Insight podcast: Overcoming planning challenges in oncology Share XBiotech Insight podcast: Overcoming planning challenges in oncologyhttps://pharmaphorum.com/podcast/biotech-insight-oncology-planning/
Vertex’s Nicola Massey: the pharmaphorum podcast Share XVertex’s Nicola Massey: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/vertex-senior-country-manager-nicola-massey/
Identifying KOLs in Growing and Emerging Markets Share XIdentifying KOLs in Growing and Emerging Marketshttps://pharmaphorum.com/partner-content/identifying-kols-in-growing-and-emerging-markets/
Social Health: The New Patient Journey Share XSocial Health: The New Patient Journeyhttps://pharmaphorum.com/partner-content/social-health-the-new-patient-journey/
RwHealth, the Artificial Intelligence provider for the NHS, promises to transform healthcare Share XRwHealth, the Artificial Intelligence provider for the NHS, promises to transform healthcarehttps://pharmaphorum.com/partner-content/rwhealth-the-artificial-intelligence-provider-for-the-nhs-promises-to-transform-healthcare/
2021 PM Society Digital Awards – Winners Announced Share X2021 PM Society Digital Awards – Winners Announcedhttps://pharmaphorum.com/partner-content/2021-pm-society-digital-awards-winners-announced/
AXON appoints Colette Balaam as its new US Managing Partner Share XAXON appoints Colette Balaam as its new US Managing Partnerhttps://pharmaphorum.com/partner-content/axon-appoints-colette-balaam-as-its-new-us-managing-partner/
Prescient Healthcare Group to Partner with Bridgepoint Development Capital Share XPrescient Healthcare Group to Partner with Bridgepoint Development Capitalhttps://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/
